Dr. Rohan Gupta, DO

Dr. Gupta practices at The Center for Cancer and Blood Disorders - Fort Worth (Magnolia Ave) in Fort Worth, Texas.

Dr. Gupta's NPI, 1326482860, was assigned on April 27, 2013. Dr. Gupta graduated from Texas College of Osteopathic Medicine in 2013. Dr. Gupta holds Texas license Q4758.

Dr. Gupta's primary practice is The Center for Cancer and Blood Disorders - Fort Worth (Magnolia Ave), at 800 W Magnolia Ave, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 759-7000.

Dr. Gupta's primary practice is The Center for Cancer and Blood Disorders - Fort Worth (Magnolia Ave) in Fort Worth, Texas. Dr. Gupta is also affiliated with Texas Health Fort Worth. The medical group on file is The Center for Cancer and Blood Disorders. Dmand AI also links Dr. Gupta to 5 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gupta practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gupta's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gupta is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Gupta's licenses on file in 2 states: Texas and California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Gupta treats.

CMS data shows 178,217 Medicare services from Dr. Gupta across 55 procedure codes in 2024, for 552 Medicare patients. Medicare paid $1,778,124 for them.

CMS counts 552 Medicare patients who saw Dr. Gupta in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gupta's median patient age at 67, with 51% women.

In 2024, Dr. Gupta wrote 2,367 Medicare Part D claims for 349 patients. 74% of them were for generic drugs. CMS names the drug for 1,999 of them, across 53 drugs with 11 or more claims each, at $4,592,034 in total drug cost. In 2023, CMS named 1,626 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Gupta for performance year 2024, reported as part of a group. Dr. Gupta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gupta as offering telehealth.

Dmand AI links 60 papers to Dr. Gupta, published from 2012 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Colorectal Neoplasms, Hematopoietic Stem Cell Transplantation and Carcinoma, Non-Small-Cell Lung. Dr. Gupta has published most often in J Gastrointest Surg. Dr. Gupta's most frequent co-authors are Idoroenyi Amanam, MD, Gaya Spolverato and Aslam Ejaz, MD.

CMS Open Payments shows 313 general payments to Dr. Gupta from 56 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Merck Sharp & Dohme Corporation paid the most, $29,166.

Dr. Gupta graduated from Texas College of Osteopathic Medicine in 2013.

Dr. Gupta is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.